Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Frederick T.
Frederick T. Chen, Hsinchu County TW
| Patent application number | Description | Published |
|---|---|---|
| 20100108980 | RESISTIVE MEMORY ARRAY - The invention is directed to a resistive memory cell on a substrate. The resistive memory cell comprises a first gate, a second gate, a common doped region, a contact plug, a bit line and a resistive memory element. The first gate and the second gate are separately disposed on the substrate. Notably, the first length of the first gate is different from the second length of the second gate. Furthermore, the common doped region of the first gate and the second gate is disposed in the substrate. The contact plug is electrically connected to the common doped region and the bit line is disposed over the substrate. Moreover, the resistive memory element is connected between the contact plug and the bit line. | 05-06-2010 |
| 20110140067 | RESISTANCE SWITCHING MEMORY - A resistance switching memory is introduced herein. The resistance switching memory includes a highly-insulating or resistance-switching material formed to cover the sidewall of a patterned metal line, and extended alongside a dielectric layer sidewall to further contact a portion of the top surface of the lower electrode. The other part of the top surface of the lower electrode is covered by an insulating layer between the top electrode and the lower electrode. An oxygen gettering metal layer in the lower electrode occupies a substantial central part of the top surface of the lower electrode and is partially covered by the highly-insulating or resistance-switching material. A switching area is naturally very well confined to the substantial central part of the oxygen gettering metal layer of the lower electrode. | 06-16-2011 |
Frederick T. Fiedorek, Princeton, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20080234367 | Methods for Treating Obesity Employing an SGLT2 Inhibitor and Compositions Thereof - Methods are provided for treating obesity or causing weight loss in a mammalian subject or patient, wherein a therapeutically effective amount of an SGLT2 inhibitor alone or optionally in combination with another anti-obesity agent, is administered to a mammalian subject or patient. In addition, a pharmaceutical composition is provided which comprises an SGLT2 inhibitor, alone or in combination with another anti-obesity agent, and a pharmaceutically acceptable carrier thereof. | 09-25-2008 |
Frederick T. Jaffin, Gilroy, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100110797 | METHOD AND APPARATUS FOR PROGRAMMING FLASH MEMORY - A method and apparatus that provides the ability to control programming pulses having different widths and/or voltages in a flash memory device. The widths and/or voltage levels of programming pulses are set to achieve programming of all memory cells of an array using a minimum number of programming pulses. | 05-06-2010 |
| 20110235429 | METHOD AND APPARATUS FOR PROGRAMMING FLASH MEMORY - A method and apparatus that provides the ability to control programming pulses having different widths and/or voltages in a flash memory device. The widths and/or voltage levels of programming pulses are set to achieve programming of all memory cells of an array using a minimum number of programming pulses. | 09-29-2011 |
Frederick T. Lamming, Denver, CO US
| Patent application number | Description | Published |
|---|---|---|
| 20110202380 | MULTIPLE SIMULTANEOUS SESSION SUPPORT BY A REMOTE TECHNICIAN - In a remote technical support system, a technical support controller receives an indication of a maximum number of support sessions to be serviced by a remote technician. Thereafter, the technical support controller receives a service request for a user device. The technical support controller determines if handling of the service request by the remote technician would cause the number of support sessions currently being handled by the remote technician to exceed the previously-indicated maximum number of support sessions. If not, the service request is added to a work queue for the remote technician. Each service request may be classified into categories such that only remote technicians associated with a given category can handle service requests for that category. Furthermore, the process of selecting a remote technician to handle a given service request can be completely automated or based on individual remote technicians selecting service requests from a preliminary queue. | 08-18-2011 |
| 20110202798 | REMOTE TECHNICAL SUPPORT EMPLOYING A CONFIGURABLE EXECUTABLE APPLICATION - In a remote technical support system, in response to a request for service, a user device receives an executable application from the technical support controller, which executable application is subsequently invoked at the user device. Additionally, the user device receives configuration information from the technical support controller. The executable application then performs technical support processing of the user device in accordance with the configuration information. The executable application can be configured, based on the configuration information, to engage in dynamic workflow, i.e., to make decisions about what activities to perform based on previous results. Because the configuration information can be selected according to the specific nature of the user device and/or the specific nature of the service request, the executable application can be tailored to best address the requesting end user's needs with minimal attention from a remote technician. | 08-18-2011 |
Frederick T. Mattrey, Bridgewater, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20110237634 | NOVEL CRYSTALLINE FORMS OF AN INHIBITOR OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 - Novel crystalline salts of 3-[4-(3-ethanesulfonyl-propyl)-bicyclo[2.2.2]oct-1-yl]-4-methyl-5-(2-trifluoromethyl-phenyl)-4H-1,2,4-triazole are potent inhibitors of 11β-hydroxysteroid dehydrogenase Type 1 and are useful for the treatment of conditions associated with Metabolic Syndrome as well as cognitive impairment. The invention also relates to pharmaceutical compositions containing these novel salts, processes to prepare these salts and their pharmaceutical compositions as well as uses thereof for the treatment of Type 2 diabetes, hyperglycemia, obesity, dyslipidemia, hypertension, and cognitive impairment. | 09-29-2011 |